2019 Glaucoma Surgery Devices Market value, size, drivers and segment analysis
The glaucoma surgery devices market insights by OG Analysis underpinned fundamental tailwinds- aging populations, increase in incidences of eye disorders such as glaucoma reflected by prevailing health issues such as diabetes, hypotension & hypertension, others, and rise in advance & high precision surgical procedures disrupting the mobility of glaucoma surgery devices market growth over the forecast period
A recent epidemiology estimates that there are up to 60 million cases of glaucoma worldwide and will increase to 80 million by 2020. Moreover, the estimated prevalence of glaucoma is 2.65% in people above 40 years of age.
The market scope is based on key product types including implants and stents, glaucoma drainage devices and glaucoma laser devices. The key End Users are Eye Hospitals, Home Settings & Ambulatory Surgical Centres and Outpatient Surgical Centres.
Further, regional analysis for glaucoma surgery devices market across the following is done
South America & Central America
Middle East & Africa
Asia-Pacific and Africa are predicted to be rapidly emerging regions of glaucoma surgery devices market driven by disproportional rise in number of glaucoma case with estimation of 111.8 million in 2040.
By device types, implants and stents continues dominating the glaucoma surgery devices share
Ease of implantation, relatively easy and appropriate for both glaucoma specialists and general ophthalmologists, particularly during cataract surgery have gained popularity for minimally invasive glaucoma stents.
CyPass Micro-Stent, iStent Trabecular Micro-bypass Stent, iStent Inject, Hydrus Microstent, XEN Gel Stent are among the widely used glaucoma surgery devices which are.
Glaucoma laser devices market is estimated to be a rapidly emerging segment of glaucoma surgery devices during the foreseen period
Strong transition towards minimal invasive and quick recovery surgical procedures escalates the glaucoma surgery devices market size and is largely driven by reduced complications and good intraocular pressure (IOP) reduction.
Accordingly, laser treatment of the trabecular meshwork such as selective laser trabeculoplasty is widely being adopted owing to benefits of no visible adverse effects and long-term effectiveness. Request sample
Prominent player creating new glaucoma surgery devices market opportunities